FDA approves new weight loss drug

A new injectable weight loss drug has been approved by the Food and Drug Administration (FDA). The drug, called Saxenda, would be available only through a prescription.

The medication, which would be taken once a day through an injection, imitates the hormone GLP-1, which tells the brain when the stomach is full. It is most effective, according to experts, when it is accompanied by a diet and exercise program.

Potential side effects include upset stomach, fatigue, dizziness and abdominal pain.  More serious health risks include pancreatitis, gall bladder disease, hypoglycemia and changes in mood and behavior.

A similar weight loss drug called Contrave was approved by the FDA in September.

NEXT: Economic insecurity tied to poor diabetes control

Sourced from: Yahoo! News, New hope for obesity patients as FDA approves Saxenda